TBPH
TBPH
KYG8807B1068
Theravance Biopharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 107.464.000 64.381.000
66.9%
Cost of Revenue -- --
--
Gross Profit -- --
--
111.066.000 106.817.000
4.0%
Operating Income -3.602.000 -42.436.000
91.5%
Pretax Income 129.247.000 -44.614.000
389.7%
Net Income Common Stockholders 105.895.000 -56.418.000
287.7%
-- --
--
-- --
--
ende